Consolidated Balance Sheets Statement (USD $) In Thousands, unless otherwise specified	Sep. 30, 2012	Dec. 31, 2011
Cash and Cash Equivalents, at Carrying Value	$ 24,658	$ 29,332
Accounts Receivable, Net	180,398	170,805
Inventory, Net	53,807	53,214
Prepaid Expense and Other Assets	42,267	33,197
TOTAL CURRENT ASSETS	301,130	286,548
Property, Plant and Equipment, Net	125,697	115,295
Intangible Assets, Net (Excluding Goodwill)	8,458	8,221
Goodwill	163,337	162,787
Deferred Tax Assets, Net, Noncurrent	12,172	13,662
Other Assets, Noncurrent	27,738	24,360
TOTAL ASSETS	638,532	610,873
Accounts Payable, Current	45,778	57,639
Employee-related Liabilities, Current	30,180	34,028
Sales and Excise Tax Payable, Current	8,490	8,566
Deferred Revenue, Current	12,833	19,154
Taxes Payable, Current	6,512	6,527
Convertible Debt, Current	45	2,344
Other Accrued Liabilities, Current	15,044	14,937
TOTAL CURRENT LIABILITIES	118,882	143,195
LONG-TERM DEBT AND CAPITAL LEASE OBLIGATIONS	213,044	223,075
Deferred Compensation Liability, Classified, Noncurrent	27,971	24,117
Deferred Tax Liabilities, Noncurrent	5,334	5,531
Other Liabilities, Noncurrent	36,469	33,300
Preferred Stock, Value, Issued	0	0
Common Stock, Value, Issued	1,233	1,262
Additional Paid in Capital, Common Stock	1,762	2,126
Retained Earnings (Accumulated Deficit)	326,058	283,660
Accumulated Other Comprehensive Income (Loss), Net of Tax	(1,699)	(1,739)
Treasury shares (at cost), xxx at 2011 and 4,218,726 at 2010	(94,380)	(107,406)
Total Core Laboratories N.V. shareholders' equity	232,974	177,903
Stockholders' Equity Attributable to Noncontrolling Interest	3,858	3,752
TOTAL EQUITY	236,832	181,655
TOTAL LIABILITIES AND EQUITY	$ 638,532	$ 610,873